Asosiy kontentga oʻtish
AkademScholar

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBasetez oradaDasturchilar API
Jurnal

Journal of Hypertension

ISSN:
0263-6352
2
h-indeks
12
Iqtiboslar
99
Asarlar
0.00
2-yillik oʻrtacha iqtibos

Ishonch signallari

1 dan 3 signal mavjud

Mustaqil ijobiy signallar — yagona “predator/qonuniy” hukmi emas, balki yaqinlashuvchi tasvir.

  • DOAJ
    Maʼlumot yoʻq
    doaj.org
  • OAK roʻyxati
    Maʼlumot yoʻq
    OAK
  • Yaroqli ISSN
    Mavjud
    ISSN

Bu axborot yorligʻi, rasmiy qaror emas. Signal yoʻqligi jazo emas — masalan, mintaqaviy jurnal DOAJ'da boʻlmasligi mumkin.

Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
01325385003581020172018201920202021202220232024202520262017: Nashrlar 4, Iqtiboslar 02018: Nashrlar 5, Iqtiboslar 02019: Nashrlar 1, Iqtiboslar 12020: Nashrlar 0, Iqtiboslar 62021: Nashrlar 1, Iqtiboslar 22022: Nashrlar 4, Iqtiboslar 02023: Nashrlar 17, Iqtiboslar 22024: Nashrlar 26, Iqtiboslar 12025: Nashrlar 9, Iqtiboslar 02026: Nashrlar 9, Iqtiboslar 0

Iqtibos tarixi

03581020172018201920202021202220232024202520262017: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 12020: Iqtiboslar 62021: Iqtiboslar 22022: Iqtiboslar 02023: Iqtiboslar 22024: Iqtiboslar 12025: Iqtiboslar 02026: Iqtiboslar 0

Nashr tarixi

01325385020172018201920202021202220232024202520262017: Nashrlar 42018: Nashrlar 52019: Nashrlar 12020: Nashrlar 02021: Nashrlar 12022: Nashrlar 42023: Nashrlar 172024: Nashrlar 262025: Nashrlar 92026: Nashrlar 9

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01220172018201920202021202220232024202520262017: h-indeks 02018: h-indeks 02019: h-indeks 12020: h-indeks 12021: h-indeks 12022: h-indeks 12023: h-indeks 22024: h-indeks 22025: h-indeks 22026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. PS 11-56 EFFICACY OF COMBINATION THERAPY USING NEBIVALOL AND TRIMETAZIDINE IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME AND STABLE ANGINA20163 iqtibos
  2. Renal denervation in the antihypertensive arsenal – knowns and known unknowns20223 iqtibos
  3. PS 14-47 COMBINED ANTIHYPERTENSIVE THERAPY WITH ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN PATIENTS WITH METABOLIC SYNDROME20161 iqtibos
  4. PS 14-53 COMPARISON OF TWO COMBINED ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME20161 iqtibos
  5. PS-82 GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) IN PATIENTS WITH ARTERIAL HYPERTENSION IN UZBEKISTAN.20161 iqtibos
  6. PS 14-54 EFFICACY AND SAFETY OF COMBINED ANTIHYPERTENSIVE THERAPY WITH LISINOPRIL AND MOXONIDINE IN PATIENTS WITH METABOLIC SYNDROME20161 iqtibos
  7. COMBINED THERAPY WITH TELMISARTAN AND AMLODIPINE ON BLOOD PRESSURE, ECHOCARDIOGRAPHIC PARAMETERS AND MICROALBUMINURIA IN PATIENTS WITH METABOLIC SYNDROME20181 iqtibos
  8. INFLUENCE OF METABOLIC SYNDROME ON RENAL FUNCTION IN PATIENTS WITH HYPERTENSION20181 iqtibos
  9. NO-SYNTHASE GENE POLYMORPHISM AND ANTIREMODELING EFFICIENCY OF NEBIVOLOL IN PATIENTS WITH ESSENTIAL HYPERTENSION20040 iqtibos
  10. ANTIREMODELING EFFICIENCY OF ENALAPRIL IN PATIENTS WITH ESSENTIAL HYPERTENSION WITH ACCOUNT I/D POLYMORPHISM OF ACE-GENE20040 iqtibos
AkademIndex'da koʻrish →